chikungunya
viru
chikv
mosquitoborn
pathogen
belong
semliki
forest
antigen
complex
genu
alphaviru
famili
togavirida
chikv
singl
posit
strand
linear
rna
genom
approxim
kb
compris
two
open
read
frame
orf
nonstructur
orf
encod
nonstructur
polyprotein
structur
orf
encod
structur
polyprotein
viru
uniqu
featur
share
chikv
member
famili
togavirida
translat
structur
polyprotein
mrna
intern
transcrib
neg
strand
templat
initi
subgenom
promot
locat
junction
region
nonstructur
structur
orf
base
genom
organ
relat
alphavirus
chikv
genom
consid
chikv
virion
spheric
capsid
icosahedr
symmetri
surround
lipid
bilay
envelop
nm
diamet
deriv
host
cell
membran
viru
bud
two
viral
glycoprotein
embed
envelop
direct
attach
host
cell
membran
subsequ
fusion
endosom
membran
respect
chikv
transmit
human
host
bloodfeed
femal
mosquito
aed
speci
particularli
ae
aegypti
ae
albopictu
often
result
clinic
condit
known
chikungunya
fever
chikf
clinic
symptom
chikv
infect
similar
arthrogen
alphavirus
like
sindbi
viru
sinv
mayaro
viru
mayv
onyongnyong
viru
onnv
ross
river
viru
rrv
arthralgia
hallmark
featur
chikv
first
isol
tanganyika
call
tanzania
becom
endem
africa
india
southeast
asia
sever
import
case
chikf
also
report
europ
occurr
chikungunya
epidem
unpredict
sever
outbreak
occur
irregular
interv
africa
asia
follow
nearli
decad
rel
quiescenc
chikv
reemerg
last
decad
caus
major
outbreak
west
africa
among
island
indian
ocean
like
madagascar
comoro
mayonett
la
time
chikv
becam
entrench
india
southeast
asia
import
chikv
case
reach
far
japan
china
taiwan
part
europ
unit
state
america
center
diseas
control
prevent
cdc
list
countri
affect
chikv
see
http
wwwcdcgovchikungunyamapindexhtml
reemerg
chikv
becom
major
health
concern
make
one
medic
import
mosquitoborn
virus
centuri
chikf
first
manifest
acut
febril
ill
accompani
headach
rash
myalgia
polyarthralgia
case
follow
chronic
pain
character
persist
arthralgia
last
week
year
acut
symptom
similar
classic
dengu
often
result
misdiagnosi
chikungunya
case
dengu
endem
area
absenc
laboratori
confirm
howev
two
differenti
sinc
chikv
infect
commonli
associ
prolong
arthralgia
affect
multipl
joint
classic
sever
dengu
manifest
hemorrhag
symptom
chikv
infect
gener
none
lifethreaten
nevertheless
epidem
la
result
chikf
case
roughli
onethird
popul
least
chikvrel
death
recent
report
sever
clinic
manifest
suggest
need
better
understand
biolog
clinic
implic
chikv
infect
addit
global
expans
increas
health
risk
associ
chikv
infect
prompt
demand
aggress
effort
find
prevent
therapeut
intervent
particular
diseas
sever
chikungunya
vaccin
strategi
explor
includ
inactiv
live
attenu
dna
chimer
vaccin
howev
issu
concern
safeti
efficaci
hamper
progress
current
vaccin
candid
similarli
drug
report
inhibit
chikv
infect
cellulo
like
chloroquin
ribavirin
arbidol
shown
signific
therapeut
benefit
clinic
case
recent
cellbas
highthroughput
assay
develop
identifi
potenti
chikv
inhibitor
one
studi
report
focu
screen
natur
compound
clinic
approv
drug
use
chikv
replicon
concomit
screen
semliki
forest
viru
sfv
surrog
infect
model
anoth
studi
screen
small
molecul
inhibitor
chikv
use
novel
targetbas
phenotyp
assay
approach
highthroughput
screen
technolog
wide
use
today
drug
discoveri
program
aim
speed
identif
potenti
activ
substanc
variou
diseas
use
highthroughput
assay
larg
collect
substanc
small
molecul
natur
product
evalu
antivir
activ
rel
short
amount
time
work
report
describ
develop
simpl
cellbas
highthroughput
assay
screen
potenti
chikv
antivir
assay
use
resazurin
oxid
nonfluoresc
blue
dye
convert
reduc
highli
fluoresc
pinkcolor
resorufin
oxidationreduct
reaction
measur
cellular
metabol
activ
cell
viabil
use
resazurin
reduct
assay
small
subset
biofocu
kinas
inhibitor
librari
screen
compound
could
inhibit
chikvassoci
cell
death
vitro
confirm
activ
doserespons
curv
viru
yield
reduct
microneutr
assay
antivir
activ
hit
compound
analyz
use
innov
imagebas
high
content
assay
understand
underli
mechan
action
addit
inhibitori
properti
chikv
primari
hit
dengu
serotyp
highcont
assay
screen
compound
librari
previous
report
investig
determin
common
novel
inhibitor
two
unrel
arbovirus
hepatocarcinoma
epitheli
cell
kind
gift
dr
katja
fink
maintain
humidifi
condit
rpmi
medium
contain
mm
hepe
welgen
south
korea
supplement
fetal
bovin
serum
fb
gibco
invitrogen
usa
uml
penicillin
streptomycin
antibiot
solut
gibco
invitrogen
usa
passag
everi
day
mosquito
cell
line
aed
albopictu
clone
gener
gift
dr
claudia
duart
do
santo
maintain
leibovitz
medium
gibco
invitrogen
usa
supplement
fb
tryptos
phosphat
broth
sigmaaldrich
usa
gentamicin
sulfat
gibco
invitrogen
usa
passag
everi
day
recombin
chikungunya
viru
green
fluoresc
protein
gfp
gene
insert
junction
region
viral
genom
kindli
provid
dr
olivi
schwartz
previous
rescu
transfect
recombin
viral
genom
rna
passag
thrice
passag
twice
follow
method
describ
elsewher
collect
small
molecul
belong
kinasefocus
chemic
librari
sourc
biofocu
galapago
belgium
refer
compound
bafilomycin
baf
chloroquin
cq
mycophenol
acid
mpa
chlorpromazin
cpz
purchas
sigmaaldrich
usa
compound
biofocu
kinas
inhibitor
librari
baf
mpa
dissolv
dimethyl
sulfoxid
dmso
sigmaaldrich
usa
cq
dissolv
cellgro
molecular
grade
water
mediatech
inc
manassa
va
autom
dispens
liquid
reagent
media
contain
cell
virus
perform
matrix
wellmat
thermo
fisher
scientif
inc
usa
highthroughput
screen
compound
biofocu
kinas
inhibitor
librari
refer
compound
dmso
vehicl
spot
onto
assay
plate
use
cybiwel
liquid
handler
cybio
germani
plate
wash
biotek
autom
liquid
washerdispens
biotek
usa
use
resazurin
purchas
sigmaaldrich
usa
dissolv
dulbecco
phosphatebuff
salin
dpb
welgen
south
korea
cell
viabil
determin
treat
resazurin
incub
hr
reduct
resazurin
resorufin
cellular
enzym
involv
oxidationreduct
reaction
termin
wv
paraformaldehyd
pfa
sigmaaldrich
usa
fix
incub
min
room
temperatur
fluoresc
intens
measur
use
v
spectrophotomet
perkin
elmer
usa
excitationemiss
wavelength
nm
measur
background
fluoresc
empti
well
contain
cell
cultur
medium
treat
resazurin
use
fixat
step
critic
resazurin
readout
allow
flexibl
autom
schedul
increas
assay
robust
decreas
variabl
popul
across
well
plate
may
occur
resorufin
reduc
colorless
nonfluoresc
hydroresorufin
fluoresc
readout
report
rel
fluoresc
unit
rfu
titrat
plaqu
assay
adapt
previous
publish
method
briefli
cell
grown
confluenc
nunc
multidish
thermo
fisher
scientif
inc
usa
wash
dpb
inocul
ml
serial
dilut
incub
hr
rock
everi
min
excess
inoculum
remov
well
fill
ml
overlay
medium
rpmi
contain
fb
antibiot
solut
carboxymethylcellulos
cmc
sigmaaldrich
usa
incub
day
humidifi
condit
remov
overlay
medium
cell
monolay
fix
pfa
room
temperatur
min
stain
wv
crystal
violet
solut
wv
crystal
violet
ethanol
dpb
crystal
violet
ethanol
purchas
sigmaaldrich
usa
viru
plaqu
count
infecti
titer
report
plaqu
form
unit
per
millilit
pfuml
cell
seed
clearplat
black
greiner
bioon
germani
cell
per
well
contain
dmso
vehicl
treat
cpz
infect
multipl
infect
moi
hr
humidifi
condit
well
fix
pfa
contain
dapi
sigmaaldrich
usa
min
room
temperatur
wash
twice
dpb
final
fill
dpb
confoc
fluoresc
imag
dapistain
nuclei
differ
field
well
acquir
use
operetta
high
content
imag
system
perkin
elmer
usa
object
len
analyz
use
custom
plugin
imag
mine
platform
softwar
develop
inhous
cell
viabil
cell
use
experiment
condit
describ
determin
resazurin
reduct
assay
cell
popul
chikv
infect
determin
confoc
fluoresc
imag
use
operetta
analyz
custom
plugin
develop
within
imagemin
platform
latter
provid
tool
manipul
analyz
highcont
screen
data
within
framework
plugin
develop
use
analyz
singl
multipl
imag
wellplat
readout
chikv
highcont
assay
analysi
base
imag
acquir
measur
two
differ
channel
dapistain
nuclei
gfpexpress
cell
signal
emit
nm
nm
respect
cell
number
quantifi
dapi
imag
use
watersh
segment
method
imag
landscap
peak
basin
altitud
pixel
intens
watersh
flood
basin
liquid
altitud
progress
increas
whole
imag
start
imag
minima
time
local
minima
reach
liquid
new
color
appear
liquid
meet
mix
form
boundari
flood
process
termin
use
threshold
prevent
inclus
background
color
region
appli
watersh
unwant
minima
due
imag
nois
filter
imag
blur
sinc
nuclei
dapi
imag
peak
rather
basin
process
appli
invert
imag
final
output
imag
nuclei
region
identifi
uniqu
color
cell
number
defin
region
chikvinfect
cell
identifi
analyz
degre
overlap
posit
gfp
signal
select
manual
defin
threshold
individu
nuclei
cell
consid
infect
least
half
nucleu
overlap
posit
gfp
signal
criterion
minim
fals
detect
due
nois
gfp
signal
select
percentag
chikvinfect
cell
defin
ratio
detect
nuclei
overlap
posit
gfp
signal
total
number
detect
nuclei
measur
rfu
valu
obtain
resazurin
reduct
assay
normal
percent
viabil
use
formula
repres
mean
valu
rfusampl
rfumock
measur
rfu
chikvinfect
treat
test
compound
dmso
vehicl
mockinfect
respect
percent
inhibit
reflect
inhibitori
effect
compound
chikv
infect
cell
calcul
use
formula
repres
mean
valu
rfusampl
rfudmso
rfumock
measur
rfu
chikvinfect
treat
test
compound
dmso
vehicl
neg
control
mockinfect
posit
control
respect
statist
valid
chikv
highthroughput
assay
determin
use
zfactor
coeffici
variat
cv
percent
inhibit
posit
neg
control
group
well
doserespons
curv
refer
compound
zfactor
defin
degre
separ
posit
neg
control
calcul
use
formula
repres
mean
standard
deviat
posit
p
neg
n
control
zfactor
posit
neg
control
group
indic
statist
reliabl
separ
posit
neg
control
cv
reflect
low
degre
variabl
within
group
briefli
freshli
trypsin
suspens
cell
inocul
moi
dispens
design
well
clearplat
black
cell
per
well
well
spot
mpa
dmso
vehicl
prior
addit
cellviru
mixtur
simul
highthroughput
screen
process
mockinfect
cell
mix
viru
medium
leibovitz
medium
supplement
fb
tryptos
phosphat
broth
gentamicin
sulfat
dispens
design
well
previous
state
plate
incub
humidifi
condit
hr
analyz
resazurin
reduct
assay
scatterplot
distribut
statist
valid
percent
inhibit
gener
use
tibco
spotfir
tibco
softwar
inc
somervil
doserespons
curv
refer
compound
determin
infect
cell
moi
presenc
variou
concentr
baf
nm
cq
mpa
hr
humidifi
condit
analyz
resazurin
reduct
assay
compound
treatment
mockinfect
cell
use
measur
toxic
doserespons
curv
percent
inhibit
percent
viabil
gener
use
graphpad
prism
graphpad
softwar
inc
san
diego
ca
curv
fit
concentr
show
inhibit
concentr
show
toxic
valu
elucid
use
softwar
nonlinear
regress
function
log
agonist
vs
respons
variabl
slope
four
paramet
unconstrain
top
bottom
valu
compound
screen
studi
belong
biofocu
kinas
inhibitor
librari
collect
synthes
small
molecul
base
predict
interact
seven
repres
subset
kinas
categor
accord
protein
conform
ligand
bind
mode
classic
well
nonclass
chemic
librari
screen
infect
use
cpz
cytotox
control
mockinfect
dmso
vehicl
posit
neg
control
respect
first
biofocu
compound
cpz
dmso
vehicl
spot
onto
clearplat
black
use
cybiwel
liquid
handler
second
freshli
trypsin
cell
suspens
inocul
moi
viru
medium
mock
infect
treatment
dispens
design
well
cell
per
well
plate
kept
humidifi
condit
hr
analyz
resazurin
reduct
assay
statist
valid
posit
neg
control
scatterplot
distribut
histogram
percent
viabil
gener
use
tibco
spotfir
primari
hit
select
use
statist
cutoff
base
percent
viabil
dmso
vehicl
control
statist
cutoff
valu
determin
use
formula
viabil
dmso
viabil
dmso
mean
standard
deviat
dmso
vehicl
control
respect
inhibitori
properti
chikv
primari
screen
hit
infect
investig
retriev
result
highcont
highthroughput
screen
biofocu
kinas
inhibitor
librari
infect
cell
deriv
report
previous
screen
campaign
us
patent
number
inocul
br
genbank
moi
presenc
compound
incub
humidifi
condit
hr
percent
infect
cell
number
determin
use
imagebas
immunofluoresc
detect
dengu
e
protein
infect
cell
flaviviru
groupspecif
monoclon
antibodi
nuclei
stain
dapi
analyz
use
anoth
custom
plugin
imag
mine
platform
compound
show
inhibit
exhibit
toxic
base
cell
number
consid
posit
hit
antivir
activ
toxic
primari
hit
chikv
highthroughput
screen
biofocu
kinas
inhibitor
librari
confirm
doserespons
curv
measur
antivir
activ
cell
mix
moi
seed
cell
per
well
clearplat
black
spot
serial
dilut
hit
compound
measur
toxic
mockinfect
cell
seed
clearplat
black
contain
hit
compound
prepar
plate
kept
humidifi
condit
hr
analyz
resazurin
reduct
assay
doserespons
curv
base
percent
inhibit
percent
viabil
gener
graphpad
prism
softwar
use
curv
fit
paramet
state
previous
select
index
si
dimensionless
valu
indic
magnitud
cytotox
effect
concentr
compound
calcul
use
formula
si
inhibitor
mitochondri
activ
shown
catalyz
reduct
resazurin
medium
certain
extent
confirm
observ
inhibitori
properti
hit
compound
chikvinduc
cell
death
result
compound
reduct
resazurin
vari
concentr
hit
compound
ad
cultur
medium
without
cell
analyz
resazurin
reduct
assay
cluster
analysi
done
use
moleculeclust
modul
pipelin
pilot
accelri
softwar
inc
san
diego
ca
usa
structur
relationship
among
primari
hit
compound
analyz
use
tanimoto
coeffici
structur
similar
core
scaffold
hit
compound
exhibit
antichikv
activ
select
structur
analysi
effect
hit
compound
product
infecti
virion
determin
plaqu
assay
briefli
cell
grown
confluenc
costar
flat
bottom
plate
corn
usa
treat
mpa
cq
hit
compound
dmso
vehicl
inocul
moi
hour
excess
inoculum
remov
well
replenish
fresh
cultur
medium
contain
amount
compound
incub
hr
humidifi
condit
titer
infecti
progeni
virion
releas
cultur
medium
determin
plaqu
assay
microneutr
assay
perform
assess
protect
confer
hit
compound
chikvinduc
cytopath
effect
cpe
adapt
previous
describ
method
use
evalu
protect
antibodi
briefli
cell
seed
costar
flat
bottom
plate
cell
per
well
kept
humidifi
condit
hr
twofold
serial
dilut
hit
compound
ad
design
well
inocul
pfu
incub
hr
excess
inoculum
remov
well
replenish
fresh
cultur
medium
contain
amount
compound
cultur
incub
hr
humidifi
condit
visual
damag
cell
monolay
caus
chikvinduc
cpe
well
fix
pfa
min
room
temperatur
stain
crystal
violet
solut
endpoint
defin
lowest
concentr
compound
inhibit
chikvinduc
cpe
assay
perform
quadrupl
infect
presenc
hit
compound
hour
analyz
imagebas
highcont
assay
cell
seed
clearplat
black
greiner
bioon
germani
cell
per
well
kept
humidifi
condit
hr
inocul
moi
presenc
mpa
cq
hit
compound
dmso
vehicl
incub
humidifi
condit
hr
cell
fix
stain
pfa
contain
dapi
min
room
temperatur
wash
thrice
dpb
confoc
fluoresc
imag
differ
area
well
acquir
use
operetta
object
len
analyz
custom
plugin
softwar
imag
mine
platform
assay
perform
quadrupl
develop
cellbas
highthroughput
assay
system
use
hepatocarcinoma
cell
line
resazurin
assess
chikvassoci
cell
death
select
target
cell
base
previou
report
demonstr
high
suscept
chikv
infect
cell
viabil
determin
measur
reduct
resazurin
highli
fluoresc
resorufin
metabol
activ
viabl
cell
use
initi
seed
densiti
cell
per
well
effect
infect
moi
cell
number
cell
viabil
measur
hr
postinfect
hpi
cpz
control
cytotox
compound
cell
number
quantifi
stain
nuclei
dapi
analyz
use
custom
plugin
imag
mine
platform
cell
viabil
measur
resazurin
reduct
assay
figur
show
number
detect
nuclei
hpi
infect
cell
start
show
signific
reduct
cell
number
begin
hpi
compar
mockinfect
p
percent
reduct
averag
number
cell
result
infect
hpi
respect
comparison
treatment
cpz
dramat
reduc
cell
number
hr
hr
base
resazurin
reduct
assay
chikvinfect
cpztreat
cell
show
signific
reduct
cell
viabil
hpi
shown
lower
fluoresc
readout
figur
treatment
cell
cpz
result
measur
fluoresc
readout
rfu
nearli
ident
empti
well
rfu
suggest
complet
abolit
metabol
activ
comparison
chikvinfect
show
higher
fluoresc
readout
rfu
still
significantli
lower
mockinfect
rfu
report
previous
shortterm
resazurin
reduct
occur
die
cell
caus
product
free
unpair
electron
good
fluoresc
signal
achiev
mockinfect
cell
distinguish
cpztreat
cell
empti
well
within
hour
treatment
resazurin
treatment
necessari
clear
separ
fluoresc
signal
mockinfect
chikvinfect
cell
data
shown
use
resazurin
reduct
assay
highthroughput
screen
chikv
inhibitor
evalu
use
zfactor
percent
inhibit
chikvinfect
dmso
vehicl
mpatreat
group
dmso
vehicl
mockinfect
group
figur
show
scatterplot
distribut
percent
inhibit
dmso
vehicl
mpa
mockinfect
group
averag
zfactor
chikvinfect
dmso
vehicl
mpatreat
group
test
plate
zfactor
rang
averag
zfactor
chikvinfect
dmso
vehicl
mockinfect
group
z
factor
rang
rfu
dmso
vehicl
neg
control
group
show
higher
degre
variabl
cv
compar
posit
control
group
mpatreat
cv
mockinfect
cv
dmso
vehicl
control
group
show
cv
slightli
higher
zfactor
mockinfect
dmso
vehicl
control
group
test
plate
indic
reason
separ
posit
neg
control
find
demonstr
reliabl
resazurin
reduct
assay
use
chikv
highthroughput
screen
figur
show
activ
toxic
refer
compound
bafilomycin
chloroquin
mycophenol
acid
chikv
infect
baf
show
valu
nm
sinc
baf
exhibit
toxic
highest
concentr
test
nm
project
valu
nm
extrapol
base
trend
percent
viabil
curv
cq
valu
determin
respect
bellshap
curv
observ
percent
inhibit
concentr
cq
approach
coincid
steep
declin
percent
viabil
indic
high
toxic
mpa
show
valu
observ
cytotox
highest
concentr
test
antivir
activ
mpa
determin
resazurin
reduct
assay
within
rang
inhibitori
concentr
mpa
previous
report
measur
antivir
activ
toxic
baf
cq
within
observ
inhibitori
properti
previous
publish
report
interestingli
mpa
treatment
chikvinfect
cell
concentr
result
higher
fluoresc
readout
compar
noninfect
treat
amount
compound
underli
mechan
observ
phenomenon
elucid
compound
subset
belong
biofocu
kinas
inhibitor
librari
screen
potenti
chikv
antivir
use
resazurin
reduct
assay
detect
highli
fluoresc
resorufin
result
reduct
resazurin
metabol
activ
viabl
cell
figur
compound
biofocu
librari
screen
dmso
measur
rfu
compound
treatment
normal
percent
viabil
use
averag
rfu
mockinfect
figur
show
overview
result
chikv
highthroughput
assay
screen
biofocu
kinas
inhibitor
librari
percent
viabil
treatment
repres
color
dot
histogram
percent
viabil
show
frequenc
distribut
treatment
biofocu
compound
cpz
dmso
mock
shown
figur
averag
percent
viabil
chikvinfect
cell
treat
dmso
vehicl
plate
plate
rang
use
upper
limit
rang
comput
statist
cutoff
viabil
base
comput
valu
statist
cutoff
round
viabil
total
compound
biofocu
kinas
inhibitor
librari
show
viabil
chikv
highthroughput
screen
select
primari
hit
give
hit
rate
comput
percent
inhibit
hit
compound
chikvassoci
cell
death
figur
among
primari
hit
identifi
chikv
compound
inhibit
previous
identifi
primari
hit
inhibit
toxic
dengu
highcont
assay
screen
biofocu
kinas
inhibitor
librari
howev
followup
compound
discontinu
hit
confirm
doserespons
curv
reveal
clear
antivir
activ
chikv
data
shown
compound
later
confirm
exhibit
antivir
activ
chikv
shown
moder
inhibitori
properti
inhibit
toxic
antivir
activ
primari
hit
chikv
highthroughput
screen
confirm
measur
inhibitori
properti
toxic
differ
concentr
use
resazurin
reduct
assay
among
hit
compound
inhibit
chikvassoci
cell
death
dosedepend
manner
figur
howev
doserespons
curv
confirm
hit
behav
differ
mycophenol
acid
except
compound
inhibitori
activ
confirm
hit
observ
plateau
none
confirm
hit
exhibit
signific
toxic
cell
highest
concentr
test
convers
show
increas
viabil
higher
concentr
base
resazurin
reduct
readout
counterscreen
determin
compound
contribut
increas
readout
carri
mix
compound
resazurin
medium
shown
tabl
increas
rfu
readout
compound
alon
thu
rule
direct
reaction
resazurin
particular
compound
confirm
hit
show
valu
rang
base
inhibit
rel
maximum
inhibit
achiev
compound
si
valu
confirm
hit
compound
summar
tabl
chemic
structur
confirm
hit
compound
shown
figur
base
structur
analysi
use
moleculeclust
modul
pipelin
pilot
compound
share
benzofuran
scaffold
common
substitut
posit
benzofuran
core
plu
amid
linker
hydrophob
group
posit
two
compound
singleton
pyrrolopyridin
base
scaffold
respect
recombin
viru
gfp
report
gene
subgenom
promot
insert
viral
genom
rna
infect
gfp
report
gene
transcrib
separ
subgenom
mrna
subgenom
mrna
util
subgenom
promot
express
green
fluoresc
protein
indic
infect
host
cell
chikv
proper
function
viral
replicas
gfp
express
chikvinfect
cell
dapistain
cell
nuclei
detect
confoc
fluoresc
imag
use
operetta
custom
plugin
imag
mine
platform
analyz
gfp
dapi
channel
acquir
confoc
fluoresc
imag
use
watersh
segment
method
gener
numer
data
total
number
nuclei
percentag
cell
express
gfp
figur
use
imagebas
highcont
assay
infect
cell
detect
hpi
cell
inocul
moi
infect
cell
within
hpi
figur
base
result
imagebas
highcont
assay
use
evalu
antivir
activ
confirm
hit
compound
chikv
infect
effect
hit
compound
infect
cell
evalu
quantifi
gfpexpress
gfp
compar
cell
morpholog
infect
inhibitori
properti
two
refer
compound
confirm
hit
compound
evalu
imag
analysi
use
custom
plugin
imag
mine
platform
see
figur
chloroquin
lysosomotrop
agent
block
viral
entri
prevent
ph
depend
fusion
inhibit
infect
mycophenol
acid
inhibitor
gmp
synthesi
result
decreas
synthesi
rna
dna
inhibit
infect
contrast
cq
mpa
none
hit
compound
exhibit
signific
inhibit
infect
benzofuran
compound
show
inhibit
except
inhibit
also
pyrrolopyridin
compound
inhibit
infect
howev
observ
presenc
hit
compound
morpholog
chikvinfect
cell
show
less
apoptot
bleb
compar
treat
dmso
vehicl
control
furthermor
cultur
supernat
chikvinfect
cell
show
decreas
log
titer
reduct
viral
titer
treat
hit
compound
compar
dmso
vehicl
control
figur
interestingli
reduct
viral
titer
result
treatment
hit
compound
compar
chloroquin
treatment
log
titer
reduct
compound
exhibit
highest
reduct
viral
titer
log
log
titer
reduct
respect
inhibit
clear
cell
monolay
caus
chikvinduc
cpe
respect
microneutr
assay
figur
recent
year
number
distribut
chikv
case
dramat
increas
culmin
devast
outbreak
record
la
rise
incid
chikungunya
outbreak
spurn
renew
effort
find
effect
vaccin
address
potenti
emerg
epidem
iron
studi
focus
chikv
antivir
drug
report
recent
use
chloroquin
quinolonecontain
drug
use
antimalari
drug
therapeut
intervent
chikvassoci
arthralgia
previous
suggest
chloroquin
show
inhibitori
properti
chikv
infect
vitro
narrow
select
index
cell
cultur
furthermor
doubleblind
placebocontrol
random
trial
treatment
acut
chikungunya
infect
la
chloriquin
show
signific
benefit
use
drug
ribavirin
nucleosid
analogu
prodrug
wide
use
antivir
sever
dna
rna
virus
also
propos
therapeut
drug
treat
chikungunyaassoci
arthriti
howev
followup
studi
pursu
anoth
antivir
drug
origin
use
treatment
influenza
respiratori
virus
arbidol
also
report
potent
antivir
properti
chikv
vitro
found
bind
domain
viral
envelop
protein
interfer
viral
attach
host
cell
receptor
recent
bioactiv
screen
method
identifi
inhibitor
alphaviru
entri
replic
report
assay
perform
particular
screen
involv
use
noncytotox
chikv
replicon
express
egfp
rluc
sfv
surrog
model
studi
report
sever
activ
eg
apigenin
chrysin
naringenin
silybin
collect
natur
product
suppress
chikv
sfv
replic
suggest
molecul
may
good
antivir
candid
alphaviru
infect
anoth
cellbas
phenotyp
assay
identifi
inhibitor
chikv
transcript
shutoff
also
recent
report
report
develop
simpl
cellbas
highthroughput
assay
use
resazurin
screen
bioactiv
molecul
chikv
resazurin
use
mainli
detect
microbi
contamin
milk
food
product
past
year
howev
last
year
sever
resazurinbas
assay
develop
screen
evalu
activ
molecul
microbi
pathogen
like
mycobacterium
sp
trichomona
vaginali
trypanosoma
brucei
leishmania
sp
aspergillu
fumigatu
well
cancer
clostridium
perfringen
resazurin
reduct
assay
assess
cell
viabil
measur
metabol
capac
cell
reduc
resazurin
also
known
alamar
blue
highli
fluoresc
resorufin
shown
posit
linear
correl
metabol
reduct
resazurin
number
viabl
cell
viabl
eukaryot
cell
convers
resazurin
resorufin
facilit
mitochondri
reductas
diaphoras
dihydrolipoamin
dehydrogenas
ec
nad
p
h
quinon
oxidoreductas
ec
flavin
reductas
ec
found
mitochondria
cytoplasm
chikv
caus
highli
cytopath
infect
wide
varieti
cell
vertebr
origin
result
rapid
death
infect
cell
apoptosi
thu
resazurin
reduct
assay
use
identifi
potenti
chikv
inhibitor
measur
cell
viabil
serv
indic
inhibitori
properti
chikvassoci
cell
death
unlik
noncytotox
chikv
replicon
use
bioactiv
screen
chikv
highthroughput
assay
use
infecti
recombin
chikv
highli
cytopath
cell
screen
compound
subset
biofocu
kinas
inhibitor
librari
use
resazurin
reduct
assay
identifi
activ
compound
inhibit
chikvassoci
cell
death
benzofuran
core
scaffold
pyrrolopyridin
scaffold
thiazolcarboxamid
scaffold
singledigit
micromolar
rang
howev
observ
inhibitori
properti
activ
compound
highest
concentr
test
enough
metabol
activ
host
cell
infect
chikv
reach
level
noninfect
cell
moreov
percentag
chikvinfect
cell
imagebas
highcont
assay
infect
diminish
significantli
even
presenc
concentr
activ
compound
indic
activ
littl
effect
viral
entri
process
viral
replic
machineri
interestingli
despit
high
percentag
chikvinfect
cell
treatment
activ
compound
reduc
viral
titer
suggest
activ
like
target
later
stage
viral
infect
ie
viru
assembl
releas
sever
factor
implic
persist
arthralgia
chikv
infect
chikv
replic
liver
target
muscl
satellit
cell
well
cell
tissu
like
muscl
joint
fibroblast
persist
chikv
infect
microgli
cell
perivascular
synovi
macrophag
shown
trigger
hostderiv
inflammatori
cytokin
respons
contribut
directli
synovi
tissu
damag
viral
persist
attribut
abil
viru
evad
host
immun
respons
differ
mechan
recent
novel
mechan
immun
evas
chikv
involv
host
cell
apoptot
machineri
describ
chikv
particl
shown
hide
apoptot
bleb
infect
cell
invad
neighbor
cell
cell
otherwis
refractori
chikv
alon
macrophag
phagocytosi
apoptot
bodi
two
activ
compound
yield
highest
reduct
chikv
viral
titer
shown
inhibit
chikvinduc
cpe
microneutr
assay
phenotyp
characterist
infect
cell
treat
benzofuran
compound
pyrrolopyridin
compound
show
dramat
reduct
format
apoptot
bleb
compar
dmso
vehicl
control
treatment
well
chloroquin
treatment
figur
find
suggest
benzofuran
pyrrolyridin
compound
imped
effici
dissemin
chikv
neighbor
cell
interf
virusinduc
apoptot
machineri
exact
role
cellular
kinas
promot
chikvinduc
apoptosi
remain
poorli
understood
report
chikv
dsrna
activ
dsrnadepend
protein
kinas
pkr
pkr
phosphoryl
translat
initi
factor
play
role
albeit
essenti
chikvassoci
cellular
translat
shutoff
iron
shown
recent
chikv
suppress
phosphoryl
regul
pkrlike
er
resid
kinas
perk
pathway
er
stress
pathway
implic
mediat
cell
apoptosi
chikv
also
report
trigger
autophag
process
promot
viral
replic
howev
chikvinduc
autophagi
delay
caspasedepend
cell
death
regul
viral
spread
kinas
like
vacuolar
protein
sort
complex
cyclindepend
kinas
involv
downregul
autophagi
investig
necessari
understand
cellular
mechan
target
activ
compound
identifi
studi
result
disrupt
chikvinduc
cpe
viru
dissemin
involv
autophagi
apoptosi
addit
sinc
chikv
display
wide
tropism
cell
cultur
interest
determin
antivir
activ
compound
relev
cell
line
primari
cell
natur
target
viru
summari
work
present
describ
applic
cellbas
highthroughput
assay
system
use
resazurin
imagebas
high
content
assay
approach
screen
kinasefocus
chemic
librari
potenti
inhibitor
chikv
two
assay
compound
interfer
chikvinduc
cpe
shown
play
role
effici
dissemin
viru
identifi
six
activ
compound
identifi
could
use
investig
mechan
involv
chikvinduc
cpe
well
serv
start
point
develop
new
antivir
drug
candid
chikv
moreov
cellbas
high
throughput
assay
use
resazurin
imagebas
highcont
assay
system
describ
could
appli
screen
compound
librari
potenti
chikv
inhibitor
